Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
49,800,360
-
Share change
-
-2,054,861
-
Total reported value
-
$4,968,187,513
-
Put/Call ratio
-
157%
-
Price per share
-
$99.74
-
Number of holders
-
397
-
Value change
-
-$262,951,825
-
Number of buys
-
168
-
Number of sells
-
250
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2020
As of 31 Mar 2020,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
397 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,800,360 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, AQR CAPITAL MANAGEMENT LLC, LSV ASSET MANAGEMENT, JPMORGAN CHASE & CO, Nuveen Asset Management, LLC, STATE STREET CORP, FMR LLC, and Boston Partners.
This page lists
398
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.